For the treatment of depression.

Intended for the treatment of urinary incontinence.

For the treatment of liver cancer, advanced non-small cell lung cancer (NSCLC), advanced colorectal cancer (CRC) and other solid tumors.

For the treatment of gram-positive infections, including multiresistant strains.

For the treatment of solid tumors.

Intended for the prevention of thrombotic events in patients with ACS.

Intended for the treatment of cervical dysplasia associated with the human papillomavirus (HPV).

Alfimeprase is being evaluated as a potential treatment for acute ischemic stroke, catheter occlusion (CO) and acute peripheral arterial occlusion (PAO).

Investigated for use/treatment in cardiac reperfusion injury, cardiovascular disorders, and coronary artery disease.

Investigated for use/treatment in attention deficit/hyperactivity disorder (ADHD), parkinson's disease, and pediatric indications.

Investigated for use/treatment in sepsis and septicemia.

Investigated for use/treatment in arrhythmia and atrial fibrillation.

Investigated for use/treatment in bone marrow transplant and graft versus host disease.

Intended for the treatment of various forms of cancer.

For the treatment of various forms of cancer.